Skip to main content

Amprius Sets February 2024 Events Schedule

Amprius Technologies, Inc. (“Amprius” or the “Company”) (NYSE: AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, today announced its schedule for February appearances and activities.

Solid-State Batteries: Innovations, Promising Start-Ups, and Future Roadmap

Date: February 14-15, 2024

Location: Virtual

Event Details: The Solid-State Batteries: Innovations, Promising Start-Ups, and Future Roadmap brings experts together to share research and development updates about solid state, lithium-ion, and other battery types. Amprius CTO Dr. Ionel Stefan will deliver a presentation titled “Transforming Electric Mobility” on February 15 at 5:55 p.m. CET/8:55 a.m. PT.

Baird Vehicle Technology and Mobility Conference

Date: February 29, 2024

Location: Virtual

Event Details: Amprius CEO Dr. Kang Sun and CFO Sandra Wallach will hold 1-on-1 meetings with investors at the event. Management will also deliver a presentation at 12:25 p.m. PT. Please contact your Baird representative if interested in scheduling a time to meet with management or attending management’s presentation.

About Amprius Technologies, Inc.

Amprius Technologies, Inc. is a leading manufacturer of high-energy and high-power lithium-ion batteries producing the industry’s highest known energy density cells. The company’s commercially available batteries deliver up to 450 Wh/kg and 1,150 Wh/L. The company’s corporate headquarters is in Fremont, California where it maintains an R&D lab and a megawatt hour manufacturing facility for the fabrication of silicon anodes and cells. To serve customer demand, Amprius entered into a lease agreement for a gigawatt hour scale facility in Brighton, Colorado. For additional information, please visit Also, see the company’s LinkedIn and Twitter pages.


Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.